Latest News for: us fda
Edit
Agios Pharma shares jump 16% as US FDA expands approval for blood disorder drug
The Economic Times 24 Dec 2025
Shares of Agios Pharmaceuticals jumped nearly 16% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder ... .
Edit
Brattleboro Reformer
24 Dec 2025
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on ...
Edit
The Milton Standard Journal
23 Dec 2025
Enveda Advances Third Asset to the Clinic With US FDA IND Clearance and Phase 1 ...
Edit
Novo Nordisk stock jumps over 7% after weight loss drug Wegovy pill gets US FDA ...
Live Mint 23 Dec 2025
Pharma giant Novo Nordisk's stock jumped over 7% during the stock market session on 23 December 2025, after the company's weight loss drug, the ‘Wegovy’ pill, received the US Food and Drug Administration (FDA) approval. Here's what you need to know.
Edit
Wegovy pill: US FDA approval granted for oral version of weight loss drug - all you need to know
The Times of India 23 Dec 2025
The US food and drug administration (FDA) has approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, offering patients an oral alternative to injectable medicines that have reshaped ...
Edit
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Gastric Cancer.
PR Newswire 23 Dec 2025
Orphan drug designation is a program where the US FDA facilitates the development and approval of treatments for rare/incurable or life-threatening diseases.
Edit
Sun Pharma share price falls 3% after US FDA conducts inspection in Baska facility. Shoul ...
Live Mint 18 Dec 2025
Edit
US FDA issues 'Official Action Indicated' status to Sun Pharma’s Baska facility after inspection
The Economic Times 18 Dec 2025
Edit
US FDA taps Merck drugs with blockbuster sales potential for national priority vouchers
The Daily Herald - St Maarten 18 Dec 2025
Edit
Times Argus
17 Dec 2025
Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma
Edit
The Joplin Globe
17 Dec 2025
Enveda Announces US FDA IND Clearance and First Patient Dosed in Phase 1 Trial of ...
Edit
December 16, 2025 Lupin Receives EIR from US FDA for its Nagpur Injectable Facility (Lupin Limited)
Public Technologies 17 Dec 2025
Global pharma major Lupin Limited (Lupin) today announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its injectable ...
Edit
December 17, 2025 Lupin Receives EIR from US FDA for its Nagpur Injectable Facility (Lupin Limited)
Public Technologies 17 Dec 2025
Global pharma major Lupin Limited (Lupin) today announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its injectable ...
Edit
Enveda Announces US FDA IND Clearance and First Patient Dosed in Phase 1 Trial of ENV-308, a First-in-Class Oral Therapy for Obesity; Appoints Nadeem Sarwar, Ph.D., MPharm, MPhil, to Lead Metabolic Disease Strategy
Pharmiweb 17 Dec 2025
Phase 1 trial initiated in the US with the first patient dosed following US FDA IND clearance ... The US Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) ...
- 1
- 2
- Next page »